题目：Investigation of Endogenous Biomarkers Applicable to Drug Interactions Involving Transporters Using Animal Models and Metabolomics
报告人：沈虹 博士（美国百时美施贵宝公司）
时间：5月14日（周一）14:00
地点：药学院254会议室
主持人：蒋惠娣 教授
Dr. Hong Shencurrently is a Principle Scientist in the Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, where he researches drug transporter activities and provides preclinical DMPK support for multiple drug discovery and development projects. He earned his doctorate in the University of Michigan, Ann Arbor. His areas of expertise in DMPK include drug transporters, drug-drug interactions, and PK/PD modeling. His research is focused towards mechanistic-based approaches to explain the handling of drugs, metabolites and endogenous biomarkers within eliminating organs, namely the liver and kidney, via the examination of relevant processes of transport and metabolism. Dr. Shen has published over 50 original articles and chapters. He was the recipient of the James R. Gillette Drug Metabolism and Pharmacokinetics Awards selected by the Drug Metabolism Division of ASPET in 2001 and 2007. He currently is a committee member of the Delaware Valley Drug Metabolism Discussion Group (DVDMDG), AAPS Drug Transporter Focus Group, International Transporter Consortium (ITC) Clinical Probe Drugs and Endogenous Biomarkers Working Group, and IQ Transporter Working Group.
主办：浙江大学药学院
承办：药物代谢与药物分析研究所
